<DOC>
	<DOC>NCT00209872</DOC>
	<brief_summary>The purpose of this study is to test the current standard of care (SOC) treatment for abdominal hysterectomy with a group receiving SOC minus epidural analgesia plus additional perioperative analgesics in terms of postoperative abilities, postoperative nausea and vomiting (PONV), pain and discharge time from the PACU (post-anaesthesia care unit).</brief_summary>
	<brief_title>Optimal Multimodal Analgesia in Abdominal Hysterectomy</brief_title>
	<detailed_description>Aim of the study: to compare postoperative complaints (PONV, pain, etc) and PACU discharge time between two groups, for patients admitted for planned abdominal hysterectomy with or without BSO: - A: standard of care (SOC) receiving paracetamol, celecoxib, epidural analgesia, dexamethasone, ondansetron and droperidol, and general anaesthesia with propofol, remifentanil and cisatracurium - B: SOC with sham epidural analgesia, preoperative gabapentin, intraoperative lidocaine, s-ketamine and sufentanil</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Gabapentin</mesh_term>
	<criteria>Planned abdominal hysterectomy with or without BSO Age above 18 years Written informed consent American Society of Anesthesiologists (ASA) class IIII Planned vaginal or laparoscopic hysterectomy Hysterectomy as part of other surgery Allergy to part of the treatment regimen Previous reactions to opioids (nausea, cognition) Previous inability to place correct epidural catheter Severe state anxiety according to the OCAP or STAI ASA class IV Dependency on alcohol, opioids or central stimulants Chronic pain condition Hemorrhagic diathesis Participation in another study</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>